Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13vPnC vs 7vPnC for Pneumococcal Colonization in Infants
NCT00508742Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- Aug 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00508742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508742.